DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

GlaxoSmithKline Pharmaceuticals Limited — Investor Presentation

NSE 2 hrs ago·4 Nov 2026, 7:37 am

GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Limited has submitted an investor presentation to the stock exchange, providing an update on its business performance and future outlook. This document typically outlines the company's strategic plans, financial results, and operational highlights for the upcoming period. For investors, such presentations are a key source of information, offering clarity on management's vision and the company's direction.

This update is significant as it helps retail investors gauge the company's growth trajectory and assess its competitive position in the market. By reviewing the presentation, stakeholders can better understand the factors driving the business and make more informed decisions regarding their investment in the stock.